Metraipolis › archive › dc_53bd4d0addf7

Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: In vitro and in vivo insights into therapeutic targeting — Europe PMC PMID:42383006

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42383006
DOI
10.1016/j.isci.2026.116479
License (as archived)
solo-consultazione
Archived
2026-10-19T07:03:46.826Z
SHA-256 of the archived text
bbc21b07aa20b7fc2ed8902d31384e254bdf5130eead095a937f250bdb3c0ebe
Stable URL of this page
https://metraipolis.com/documento/dc_53bd4d0addf7

How to cite

Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: In vitro and in vivo insights into therapeutic targeting — Europe PMC PMID:42383006 — Europe PMC (en), https://europepmc.org/article/MED/42383006 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53bd4d0addf7 (Metraipolis archive dc_53bd4d0addf7, sha256 bbc21b07aa20b7fc2ed8902d31384e254bdf5130eead095a937f250bdb3c0ebe)
BibTeX
@misc{dc53bd4d0addf7,
  title = {Dysregulation of sphingolipid-metabolizing enzymes in Friedreich's ataxia: In vitro and in vivo insights into therapeutic targeting — Europe PMC PMID:42383006},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42383006},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53bd4d0addf7; sha256 bbc21b07aa20b7fc2ed8902d31384e254bdf5130eead095a937f250bdb3c0ebe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42383006. Agents can read the archived copy with the MCP tool read_document.